Subscribe free

HPB & Spleen ·

Complete pathological response leads to improved survival in pancreatic cancer patients

Following neoadjuvant treatment with FOLFIRINOX for pancreatic adenocarcinoma, researchers observed a median overall survival of 177 months for patients achieving complete pathological response (cpr). Among 101 patients studied, overall survival rates after 1, 3, 5, and 10 years were 93%, 75%, 63%, and 51%, respectively. However, one-third experienced disease recurrence, with preoperative chemoradiotherapy correlated to worse outcomes, indicating it as a significant negative prognostic factor for both overall and recurrence-free survival.

Journal Article by Addeo P, Muzzolini M (…) Bachellier P et 38 al. in Ann Surg Oncol

© 2025. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →